CN102716515A - 一种修复半月板撕裂的生物材料及其制备方法 - Google Patents
一种修复半月板撕裂的生物材料及其制备方法 Download PDFInfo
- Publication number
- CN102716515A CN102716515A CN2012102247245A CN201210224724A CN102716515A CN 102716515 A CN102716515 A CN 102716515A CN 2012102247245 A CN2012102247245 A CN 2012102247245A CN 201210224724 A CN201210224724 A CN 201210224724A CN 102716515 A CN102716515 A CN 102716515A
- Authority
- CN
- China
- Prior art keywords
- cell
- preparation
- collagen
- chondrocyte
- meniscus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 74
- 206010072970 Meniscus injury Diseases 0.000 title claims abstract description 68
- 239000012620 biological material Substances 0.000 title claims abstract description 43
- 102000008186 Collagen Human genes 0.000 claims abstract description 85
- 108010035532 Collagen Proteins 0.000 claims abstract description 85
- 229920001436 collagen Polymers 0.000 claims abstract description 85
- 210000004027 cell Anatomy 0.000 claims abstract description 66
- 239000000463 material Substances 0.000 claims abstract description 52
- 239000011159 matrix material Substances 0.000 claims abstract description 50
- 238000000034 method Methods 0.000 claims abstract description 44
- 230000008439 repair process Effects 0.000 claims abstract description 20
- 230000008569 process Effects 0.000 claims abstract description 13
- 210000001612 chondrocyte Anatomy 0.000 claims description 74
- 238000012258 culturing Methods 0.000 claims description 28
- 230000001413 cellular effect Effects 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 23
- 239000012531 culture fluid Substances 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 20
- 238000011081 inoculation Methods 0.000 claims description 20
- 210000000130 stem cell Anatomy 0.000 claims description 13
- 241001465754 Metazoa Species 0.000 claims description 12
- 239000011248 coating agent Substances 0.000 claims description 12
- 238000000576 coating method Methods 0.000 claims description 12
- 239000000835 fiber Substances 0.000 claims description 12
- 230000008859 change Effects 0.000 claims description 11
- 108010081589 Becaplermin Proteins 0.000 claims description 10
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 10
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 10
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 10
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 10
- 238000007766 curtain coating Methods 0.000 claims description 10
- 239000003797 essential amino acid Substances 0.000 claims description 10
- 235000020776 essential amino acid Nutrition 0.000 claims description 10
- 238000001746 injection moulding Methods 0.000 claims description 10
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 10
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 10
- 239000011148 porous material Substances 0.000 claims description 9
- 210000001691 amnion Anatomy 0.000 claims description 8
- 238000004113 cell culture Methods 0.000 claims description 8
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 7
- 102000013275 Somatomedins Human genes 0.000 claims description 7
- 238000010382 chemical cross-linking Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000002131 composite material Substances 0.000 claims description 6
- 239000003431 cross linking reagent Substances 0.000 claims description 6
- 238000012423 maintenance Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 239000001963 growth medium Substances 0.000 claims description 5
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 5
- 229940054269 sodium pyruvate Drugs 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- 241000283690 Bos taurus Species 0.000 claims description 4
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 4
- 238000004132 cross linking Methods 0.000 claims description 4
- HCZKYJDFEPMADG-UHFFFAOYSA-N nordihydroguaiaretic acid Chemical compound C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 claims description 4
- 150000002924 oxiranes Chemical class 0.000 claims description 4
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 claims description 3
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims description 3
- 239000011243 crosslinked material Substances 0.000 claims description 3
- 230000004069 differentiation Effects 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 210000000813 small intestine Anatomy 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 claims description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 claims description 2
- SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 150000001540 azides Chemical class 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 150000001718 carbodiimides Chemical class 0.000 claims description 2
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 210000005258 dental pulp stem cell Anatomy 0.000 claims description 2
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 2
- 210000004700 fetal blood Anatomy 0.000 claims description 2
- 210000004195 gingiva Anatomy 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- -1 oligomer Substances 0.000 claims description 2
- 210000003516 pericardium Anatomy 0.000 claims description 2
- 210000004303 peritoneum Anatomy 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 150000004053 quinones Chemical class 0.000 claims description 2
- 210000003954 umbilical cord Anatomy 0.000 claims description 2
- 238000010276 construction Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 41
- 230000006378 damage Effects 0.000 abstract description 14
- 239000012528 membrane Substances 0.000 abstract description 7
- 230000017423 tissue regeneration Effects 0.000 abstract description 7
- 230000036770 blood supply Effects 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 5
- 210000003321 cartilage cell Anatomy 0.000 abstract description 5
- 230000004071 biological effect Effects 0.000 abstract description 3
- 238000004891 communication Methods 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 238000001802 infusion Methods 0.000 abstract 1
- 230000005499 meniscus Effects 0.000 description 31
- 241000283973 Oryctolagus cuniculus Species 0.000 description 19
- 210000000629 knee joint Anatomy 0.000 description 12
- 102000004127 Cytokines Human genes 0.000 description 8
- 108090000695 Cytokines Proteins 0.000 description 8
- 230000035876 healing Effects 0.000 description 7
- 210000000689 upper leg Anatomy 0.000 description 7
- 239000007943 implant Substances 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 210000004379 membrane Anatomy 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 238000011069 regeneration method Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 210000001188 articular cartilage Anatomy 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 239000002932 luster Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 2
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
- 101710098940 Pro-epidermal growth factor Proteins 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 230000005021 gait Effects 0.000 description 2
- 210000003701 histiocyte Anatomy 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000009958 sewing Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000001179 synovial fluid Anatomy 0.000 description 2
- 210000002437 synoviocyte Anatomy 0.000 description 2
- 210000002303 tibia Anatomy 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010024452 Ligament laxity Diseases 0.000 description 1
- 206010069364 Meniscal degeneration Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 241000053227 Themus Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 230000022159 cartilage development Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000001136 chorion Anatomy 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002219 extraembryonic membrane Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 210000003314 quadriceps muscle Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000004353 tibial menisci Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210224724.5A CN102716515B (zh) | 2012-07-02 | 2012-07-02 | 一种修复半月板撕裂的生物材料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210224724.5A CN102716515B (zh) | 2012-07-02 | 2012-07-02 | 一种修复半月板撕裂的生物材料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102716515A true CN102716515A (zh) | 2012-10-10 |
CN102716515B CN102716515B (zh) | 2014-01-29 |
Family
ID=46942467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210224724.5A Expired - Fee Related CN102716515B (zh) | 2012-07-02 | 2012-07-02 | 一种修复半月板撕裂的生物材料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102716515B (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103349798A (zh) * | 2013-07-26 | 2013-10-16 | 江西瑞济生物工程技术有限公司 | 一种复合活性羊膜材料及其制备方法和应用,以及一种复合活性羊膜宫腔修复支架 |
CN103394126A (zh) * | 2013-07-11 | 2013-11-20 | 陕西佰傲再生医学有限公司 | 一种软骨修复材料及其制备方法 |
CN103520780A (zh) * | 2013-10-24 | 2014-01-22 | 陕西瑞盛生物科技有限公司 | 一种生物羊膜及其制备方法 |
CN103920188A (zh) * | 2013-01-16 | 2014-07-16 | 陕西博鸿生物科技有限公司 | 一种组织工程半月板修复片及其制备方法 |
CN104357385A (zh) * | 2014-11-17 | 2015-02-18 | 四川大学华西医院 | 一种半月板组织来源的间充质干细胞及其制备方法和鉴定 |
CN106967686A (zh) * | 2017-03-31 | 2017-07-21 | 北昊干细胞与再生医学研究院有限公司 | 软骨细胞体外端粒延长增殖培养的方法及人源组织工程化再生软骨 |
CN107029296A (zh) * | 2017-03-03 | 2017-08-11 | 北京博辉瑞进生物科技有限公司 | 一种引导骨再生的骨膜修补片、制备方法和应用 |
CN108430527A (zh) * | 2015-12-21 | 2018-08-21 | 美敦力瓦斯科尔勒公司 | 制备干燥交联组织的方法 |
CN111511900A (zh) * | 2017-11-09 | 2020-08-07 | 南加利福尼亚大学阿尔弗雷德·E·曼恩生物医学工程研究所 | 用于骨再生的干细胞和装置 |
CN111643734A (zh) * | 2020-05-25 | 2020-09-11 | 内蒙古自治区中医药研究所 | 一种应用于半月板损伤修复的脱细胞基质 |
CN114642769A (zh) * | 2022-05-19 | 2022-06-21 | 茂名市人民医院 | 一种仿生结构半月板 |
CN114732949A (zh) * | 2022-03-25 | 2022-07-12 | 上海工程技术大学 | 具有取向结构的肩袖补片及其制备方法 |
WO2022156685A1 (zh) * | 2021-01-20 | 2022-07-28 | 上海软馨生物科技有限公司 | 一种凝胶软骨接种于框架结构实现软骨再生的方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005506121A (ja) * | 2001-10-18 | 2005-03-03 | ライフセル コーポレーション | 組織および器官のリモデリング |
US20070065943A1 (en) * | 2005-09-19 | 2007-03-22 | Histogenics Corp. | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
CN101252948A (zh) * | 2005-09-02 | 2008-08-27 | 埃德盖斯特利希索恩化学工业股份公司 | 修复半月板撕裂的方法 |
WO2009026392A1 (en) * | 2007-08-20 | 2009-02-26 | Histogenics Corporation | A method for improvement of differentiation of mesenchymal stem cells using a double-structured tissue implant |
CN101573148A (zh) * | 2006-11-16 | 2009-11-04 | 利兹大学 | 半月板移植用组织的制备 |
CN102188748A (zh) * | 2011-04-29 | 2011-09-21 | 成都军区昆明总医院 | 一种新型软骨细胞外基质膜及其制备方法 |
-
2012
- 2012-07-02 CN CN201210224724.5A patent/CN102716515B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005506121A (ja) * | 2001-10-18 | 2005-03-03 | ライフセル コーポレーション | 組織および器官のリモデリング |
CN101252948A (zh) * | 2005-09-02 | 2008-08-27 | 埃德盖斯特利希索恩化学工业股份公司 | 修复半月板撕裂的方法 |
US20070065943A1 (en) * | 2005-09-19 | 2007-03-22 | Histogenics Corp. | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
CN101573148A (zh) * | 2006-11-16 | 2009-11-04 | 利兹大学 | 半月板移植用组织的制备 |
WO2009026392A1 (en) * | 2007-08-20 | 2009-02-26 | Histogenics Corporation | A method for improvement of differentiation of mesenchymal stem cells using a double-structured tissue implant |
CN102188748A (zh) * | 2011-04-29 | 2011-09-21 | 成都军区昆明总医院 | 一种新型软骨细胞外基质膜及其制备方法 |
Non-Patent Citations (2)
Title |
---|
卢华定等: "I型胶原半月板支架负载纤维软骨细胞体外培养", 《中国矫形外科杂志》 * |
聂芳菲等: "脱细胞基质在软骨组织工程中的应用", 《中国修复重建外科杂志》 * |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103920188A (zh) * | 2013-01-16 | 2014-07-16 | 陕西博鸿生物科技有限公司 | 一种组织工程半月板修复片及其制备方法 |
CN103920188B (zh) * | 2013-01-16 | 2016-04-27 | 陕西博鸿生物科技有限公司 | 一种组织工程半月板修复片及其制备方法 |
CN103394126A (zh) * | 2013-07-11 | 2013-11-20 | 陕西佰傲再生医学有限公司 | 一种软骨修复材料及其制备方法 |
CN103349798A (zh) * | 2013-07-26 | 2013-10-16 | 江西瑞济生物工程技术有限公司 | 一种复合活性羊膜材料及其制备方法和应用,以及一种复合活性羊膜宫腔修复支架 |
CN103520780A (zh) * | 2013-10-24 | 2014-01-22 | 陕西瑞盛生物科技有限公司 | 一种生物羊膜及其制备方法 |
CN103520780B (zh) * | 2013-10-24 | 2015-03-25 | 陕西瑞盛生物科技有限公司 | 一种生物羊膜及其制备方法 |
CN104357385A (zh) * | 2014-11-17 | 2015-02-18 | 四川大学华西医院 | 一种半月板组织来源的间充质干细胞及其制备方法和鉴定 |
CN108430527A (zh) * | 2015-12-21 | 2018-08-21 | 美敦力瓦斯科尔勒公司 | 制备干燥交联组织的方法 |
CN107029296A (zh) * | 2017-03-03 | 2017-08-11 | 北京博辉瑞进生物科技有限公司 | 一种引导骨再生的骨膜修补片、制备方法和应用 |
CN107029296B (zh) * | 2017-03-03 | 2020-09-29 | 北京博辉瑞进生物科技有限公司 | 一种引导骨再生的骨膜修补片、制备方法和应用 |
CN106967686A (zh) * | 2017-03-31 | 2017-07-21 | 北昊干细胞与再生医学研究院有限公司 | 软骨细胞体外端粒延长增殖培养的方法及人源组织工程化再生软骨 |
CN106967686B (zh) * | 2017-03-31 | 2019-11-08 | 北昊干细胞与再生医学研究院有限公司 | 软骨细胞体外端粒延长增殖培养的方法及人源组织工程化再生软骨 |
CN111511900A (zh) * | 2017-11-09 | 2020-08-07 | 南加利福尼亚大学阿尔弗雷德·E·曼恩生物医学工程研究所 | 用于骨再生的干细胞和装置 |
US11484625B2 (en) | 2017-11-09 | 2022-11-01 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Stem cells and devices for bone regeneration |
CN111643734A (zh) * | 2020-05-25 | 2020-09-11 | 内蒙古自治区中医药研究所 | 一种应用于半月板损伤修复的脱细胞基质 |
WO2022156685A1 (zh) * | 2021-01-20 | 2022-07-28 | 上海软馨生物科技有限公司 | 一种凝胶软骨接种于框架结构实现软骨再生的方法 |
CN114732949A (zh) * | 2022-03-25 | 2022-07-12 | 上海工程技术大学 | 具有取向结构的肩袖补片及其制备方法 |
CN114732949B (zh) * | 2022-03-25 | 2023-01-24 | 上海工程技术大学 | 具有取向结构的肩袖补片及其制备方法 |
CN114642769A (zh) * | 2022-05-19 | 2022-06-21 | 茂名市人民医院 | 一种仿生结构半月板 |
Also Published As
Publication number | Publication date |
---|---|
CN102716515B (zh) | 2014-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102716515B (zh) | 一种修复半月板撕裂的生物材料及其制备方法 | |
US10456501B2 (en) | Compositions and methods for cardiac therapy | |
KR101650957B1 (ko) | 세포외 기질 조성물 | |
US20140227235A1 (en) | Cartilage cell treatment comprising collagen, hyaluronic acid derivative, and stem cell derived from mammal umbilical cord | |
Huang et al. | The challenge in using mesenchymal stromal cells for recellularization of decellularized cartilage | |
Ye et al. | Bioengineering of articular cartilage: past, present and future | |
KR102311639B1 (ko) | 심근조직 재생용 3차원 구조체의 제조방법 | |
Chen et al. | Transplantation of amniotic scaffold-seeded mesenchymal stem cells and/or endothelial progenitor cells from bone marrow to efficiently repair 3-cm circumferential urethral defect in model dogs | |
CN102892880A (zh) | 生物工程化组织构建物及其制备和使用方法 | |
CN101084026A (zh) | 含有生脂间充质干细胞的聚乙二醇-双丙烯酸酯(pegda)交联的水凝胶 | |
WO2010111263A1 (en) | Tissue engineering scaffolds and methods of use | |
CN103920188B (zh) | 一种组织工程半月板修复片及其制备方法 | |
JP2020105208A (ja) | 骨部位を処理するために有用な細胞がシードされた組成物および方法 | |
Dadgar et al. | Cartilage tissue engineering using injectable functionalized Demineralized Bone Matrix scaffold with glucosamine in PVA carrier, cultured in microbioreactor prior to study in rabbit model | |
Zhang et al. | Preparation and application of decellularized ECM-based biological scaffolds for articular cartilage repair: a review | |
CN103394126B (zh) | 一种软骨修复材料及其制备方法 | |
CN110237302A (zh) | 一种关节软骨修复材料的制备方法-自体富血小板血浆结合透明质酸水凝胶 | |
Thomas et al. | In vitro and in vivo efficacy of naturally derived scaffolds for cartilage repair and regeneration | |
Mahmoud et al. | Treatment strategies for meniscal lesions: from past to prospective therapeutics | |
JP7321152B2 (ja) | 軟骨移植片の再細胞化を可能にするエラスチン低減 | |
CN109498841B (zh) | 一种生物型骨膜修复材料及其制备方法 | |
Sundaram et al. | Tissue engineering and regenerative medicine | |
Taylor et al. | Whole-heart scaffolds—how to build a heart | |
Dzilic et al. | Regenerative Medicine for the Treatment of Congenital Heart Disease | |
ten Dam | Future perspectives of novel donor-independent tissue transplantation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Biological material for repairing meniscus tear and preparation method for biological material Effective date of registration: 20150731 Granted publication date: 20140129 Pledgee: CITIC Bank Limited by Share Ltd. Xi'an branch Pledgor: SHAANXI BOHONG BIOTECHNOLOGY Co.,Ltd.|SHAANXI BIOCELL BIOTECHNOLOGY Co.,Ltd. Registration number: 2015990000623 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CP01 | Change in the name or title of a patent holder |
Address after: 710065 Shaanxi City, south of the Second Ring Road, Qinglong District Albert urban vision, building 11003, No. 1, No. Patentee after: SHAANXI BIOHONG BIOTECHNOLOGY GROUP CO.,LTD. Address before: 710065 Shaanxi City, south of the Second Ring Road, Qinglong District Albert urban vision, building 11003, No. 1, No. Patentee before: SHAANXI BOHONG BIOTECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190313 Granted publication date: 20140129 Pledgee: CITIC Bank Limited by Share Ltd. Xi'an branch Pledgor: GUANGDONG BIOCELL BIOTECHNOLOGY Co.,Ltd.|SHAANXI BIOHONG BIOTECHNOLOGY GROUP CO.,LTD. Registration number: 2015990000623 |
|
PM01 | Change of the registration of the contract for pledge of patent right | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20190312 Registration number: 2015990000623 Pledgor after: SHAANXI BIOHONG BIOTECHNOLOGY GROUP CO.,LTD. Pledgor after: GUANGDONG BIOCELL BIOTECHNOLOGY Co.,Ltd. Pledgor before: SHAANXI BOHONG BIOTECHNOLOGY Co.,Ltd. Pledgor before: SHAANXI BIOCELL BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200317 Address after: 710024 floor 4, building B1, standard workshop community, No. 599, Fangyuan Third Road, modern textile industrial park, Baqiao District, Xi'an City, Shaanxi Province Patentee after: Xi'an Bohong Biotechnology Co.,Ltd. Address before: 710065, Shaanxi, Xi'an, South Second Ring Qinglong District, Albert City Vision 1, No. 11003 Patentee before: SHAANXI BIOHONG BIOTECHNOLOGY GROUP Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140129 |